Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry

被引:24
作者
Li, YN
Tattam, B
Brown, KF
Seale, JP
机构
[1] UNIV SYDNEY,DEPT PHARM,SYDNEY,NSW 2006,AUSTRALIA
[2] UNIV SYDNEY,DEPT PHARMACOL,SYDNEY,NSW 2006,AUSTRALIA
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 683卷 / 02期
关键词
budesonide; glucocorticosteroids;
D O I
10.1016/0378-4347(96)00111-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A highly sensitive and selective method has been developed for the simultaneous quantification of 22R- and 22S-epimers of budesonide in human plasma. The drug was isolated from human plasma using C-18 solid-phase extraction cartridges and was acetylated with a mixture of 12.5% acetic anhydride and 12.5% triethylamine in acetonitrile to form the 21-acetyl derivatives. Deuterium-labelled budesonide was synthesized and determined to have an isotopic purity >99%. This was used as the internal standard. Epimers were quantified by automated liquid chromatography-atmospheric pressure chemical ionization mass spectrometry, operating in selected ion mode at m/z 473.2 and m/z 476.2. Linear responses were observed for both epimers over the range 0.25 to 10.0 ng/ml. The average recoveries of 22R- and 22S-epimers of budesonide from human plasma were 87.4% and 87.0%, respectively. The lower limit of quantification for each epimer was 0.25 ng/ml, corresponding to 50.0 pg of analyte on column. Within- and between-day coefficients of variation were 8.6% and 4.0%, respectively.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 17 条
[1]   A SENSITIVE RADIOIMMUNOASSAY FOR BUDESONIDE IN PLASMA [J].
AHERNE, GW ;
LITTLETON, P ;
THALEN, A ;
MARKS, V .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1982, 17 (05) :559-565
[2]   INFLUENCE OF 16-ALPHA,17-ALPHA-ACETAL SUBSTITUTION AND STEROID NUCLEUS FLUORINATION ON THE TOPICAL TO SYSTEMIC ACTIVITY RATIO OF GLUCOCORTICOIDS [J].
BRATTSAND, R ;
THALEN, A ;
ROEMPKE, K ;
KALLSTROM, L ;
GRUVSTAD, E .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1982, 16 (06) :779-786
[3]  
BRATTSAND R, 1982, EUR J RESPIR DIS, V63, P62
[4]   BUDESONIDE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY IN ASTHMA AND RHINITIS [J].
CLISSOLD, SP ;
HEEL, RC .
DRUGS, 1984, 28 (06) :485-518
[5]  
EDSBACKER S, 1987, DRUG METAB DISPOS, V15, P403
[6]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF BUDESONIDE IN BRONCHOALVEOLAR LAVAGE OF ASTHMATIC-PATIENTS [J].
FAOUZI, MA ;
DINE, T ;
LUYCKX, M ;
BRUNET, C ;
GRESSIER, B ;
CAZIN, M ;
WALLAERT, B ;
CAZIN, JC .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1995, 664 (02) :463-467
[7]  
HEIJER A, 1981, Journal of International Medical Research, V9, P239
[8]   DETERMINATION OF (22R,S)BUDESONIDE IN HUMAN PLASMA BY AUTOMATED LIQUID-CHROMATOGRAPHY THERMOSPRAY MASS-SPECTROMETRY [J].
LINDBERG, C ;
BLOMQVIST, A ;
PAULSON, J .
BIOLOGICAL MASS SPECTROMETRY, 1992, 21 (11) :525-533
[9]   INCREASING THERMOSPRAY RESPONSE FOR CORTISOL BY DERIVATIZATION [J].
PAULSON, J ;
LINDBERG, C .
JOURNAL OF CHROMATOGRAPHY, 1991, 554 (1-2) :149-154
[10]  
PIPKORN U, 1980, Rhinology (Utrecht), V18, P171